These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11365686)

  • 1. T-20: new trial enrolling, 9 U.S. cities.
    James JS
    AIDS Treat News; 1998 Aug; (No 300):1-3. PubMed ID: 11365686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-20: 5-drug combination trial for heavily treated NNRTI-naive patients now recruiting.
    AIDS Treat News; 1999 Jul; (No 323):2-3. PubMed ID: 11366569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-20--a fusion drug, first of several to come.
    TreatmentUpdate; 1998 Dec; 10(10):2. PubMed ID: 11366015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-20 and Trimeris.
    James JS
    AIDS Treat News; 1998 Apr; (No 293):1-6. PubMed ID: 11365387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starving the virus.
    Res Initiat Treat Action; 1999 Apr; 5(2):32-3. PubMed ID: 11366283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
    AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral resistance testing: practical issues and future opportunities - interview with Thomas Merigan, M.D. Interview by John S. James.
    Merigan T
    AIDS Treat News; 1999 Apr; (No 316):1-6. PubMed ID: 11366300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-20: a new class of drugs.
    STEP Perspect; 1999; 99(1):6. PubMed ID: 11367163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New study: stopping therapy.
    Vazquez E
    Posit Aware; 1999; 10(4):25. PubMed ID: 11366800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-20: first of a new class of anti-HIV drugs.
    Hanna L
    BETA; 1999 Jan; 12(1):7-8. PubMed ID: 11367243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug watch.
    Whitson S
    Posit Aware; 1999; 10(3):16-7. PubMed ID: 11366758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New vaccine+HAART treatment trial enrolling at NIH. National Institutes of Health.
    James JS
    AIDS Treat News; 1998 Aug; (No 300):3-4. PubMed ID: 11365687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The latest antiviral news.
    Vazquez E
    Posit Aware; 1999; 10(2):44. PubMed ID: 11366851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stop-and-go therapy.
    Posit Aware; 2000; 11(1):23. PubMed ID: 11366338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment news: new options for the future.
    Elliot-Lopez C
    Women Alive; 2000; ():7. PubMed ID: 11367320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose cyclosporin: government trial recruiting, CD4 count over 500.
    AIDS Treat News; 1998 Dec; (No 308):5-6. PubMed ID: 11366076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIH starts STI study.
    AIDS Patient Care STDS; 2000 Apr; 14(4):225. PubMed ID: 10806644
    [No Abstract]   [Full Text] [Related]  

  • 20. "Drug holidays" provide no benefits in HIV treatment.
    Public Health Rep; 2004; 119(1):97. PubMed ID: 15174493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.